Alkame Holdings, Inc. Closes Acquisition Of Intellectual Property And Assets Of Xtreme Technologies, Inc.

LAS VEGAS, NV--(Marketwired - January 22, 2015) - Alkame Holdings, Inc. (OTCQB: ALKM), a publicly traded health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly products announced today it has closed on its definitive agreement to acquire all intellectual property and assets of Xtreme Technologies, Inc. (“Xtreme”). Alkame Holdings, Inc. now owns the patents and rights on the proprietary technologically advanced process in water treatment systems for complete hydration and expands the Company’s distribution global wide.

Alkame’s patented technology creates water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. This patented technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.

According to Alkame Holdings, Inc. CEO, Robert Eakle, “This is a major milestone for our company. This acquisition allows us to now expand our distribution globally, includes a testing and manufacturing facility, annual revenue of over a million, and allows us to immediately enter the pet industry with existing major customers such as Walmart and Petco. In addition, we no longer have licensing fees for use of the technology, thus lowering our costs and improve margins significantly. Our primary objective is to use the patented technology we have now acquired underlying in our brand, and then to introduce, promote, aggressively market and establish greater channels of distribution to sell our product to a wide range of consumers.”

Eakle added, “We look forward to continuing our distribution in the United States, and look ahead with great promise to Canada and Mexico, and then globally. In addition, now that we have acquired the rights to the technology, we are aggressively exploring other uses of our water so that we can diversify our portfolio of products. We can now show proof of concept of our water filtration and oxygenation system to global markets in different industries such as pets and aquaculture. This acquisition truly moves us from just a bottled water company into a holding company with numerous revenue streams.”

About Alkame Holdings, Inc. (ALKM)
Alkame Holdings, Inc. is a publicly traded health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company’s wholly-owned subsidiary, Alkame Water, Inc., markets and distributes micro-clustered, alkaline, antioxidant and oxygenated bottled water utilizing an exclusive patented formula and technology. Alkame uses this patented technology to create water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. This patented technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.

For more information visit: www.alkameholdingsinc.com

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.